Stocks · Healthcare · Medical - Healthcare Information Services
Certara, Inc. CERT
$9.36 +0.21% Close, Oct 2, 2026 · NASDAQ · Market cap $1.46B
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-0.44, down 981.5% year over year.
- The stock is in an uptrend: above its 200-day average for 49 trading days, with the 50-day average above the 200-day.
- Over the past year the stock returned -30.0%, behind the S&P 500 by 45.1 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 31%
- EPS growth (TTM, YoY)Bottom 2%
- FCF growth (TTM, YoY)Bottom 25%
- Revenue growth, 3-year CAGRBottom 43%
- Revenue growth accelerationBottom 24%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 32%
- Gross marginBottom 44%
- Operating marginTop 40%
- Accruals (lower is better)Top 32%
- Net debt / EBITDA (lower is better)Bottom 48%
- Interest coverTop 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 43%
- Free-cash-flow yieldTop 21%
- EBITDA / enterprise valueTop 21%
- Sales / enterprise valueTop 46%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 11%
- 6-month returnTop 13%
- 1-year return vs S&P 500Bottom 22%
- Distance from 52-week highBottom 50%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 34%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 12%
- Upside to consensus price targetBottom 6%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 29%
- Maximum drawdown, 3 yearsBottom 39%
- Beta vs S&P 500 (lower is better)Bottom 19%
- Net debt / EBITDA (lower is better)Bottom 48%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.4% | 0.7% | ↓ |
| Gross margin | 61.1% | 58.3% | ↓ |
| Operating margin | 6.4% | 1.9% | ↓ |
| FCF margin | 19.1% | 15.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 0.7% | 6.4% | ↓ | Bottom 31% |
| EPS growth (TTM, YoY) | -981.5% | — | Bottom 2% | |
| Gross margin | 58.3% | 61.1% | ↓ | Bottom 44% |
| Operating margin | 1.9% | 6.4% | ↓ | Top 40% |
| Net margin | -16.7% | 2.0% | ↓ | — |
| Free-cash-flow margin | 15.1% | 19.1% | ↓ | — |
| Return on invested capital | 0.6% | — | Top 32% | |
| Revenue growth, 3-year CAGR | 7.7% | — | Bottom 43% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -10.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 7.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +6.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.29×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 5.15%
- Shareholder yield
- 5.15%
- Share count change, 1 year
- -4.1%
- Share count change, 3-year CAGR
- -1.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -4.9%
- Average 2-day reaction, last 8
- -2.8%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $8.50
- Target vs current price
- -9.2%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 44%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -10.4% | -4.6% | -1.3% | +1.3% | — |
| May 11, 2026 | -18.2% | -18.7% | -29.0% | -17.3% | +26.9% |
| Feb 26, 2026 | -18.2% | +3.2% | +11.5% | -7.4% | -21.5% |
| Nov 6, 2025 | +27.3% | -2.6% | -28.4% | -17.3% | -33.0% |
| Aug 6, 2025 | -30.0% | -3.3% | +9.0% | +6.5% | +17.4% |
| May 5, 2025 | +7.7% | -1.6% | -7.8% | -15.3% | -21.2% |
| Feb 26, 2025 | +15.4% | -0.4% | -4.3% | -16.6% | -9.8% |
| Nov 6, 2024 | +18.2% | +5.8% | +2.8% | +5.5% | +34.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.08 | $0.09 | -10.4% | $93.3M |
| May 11, 2026 | $0.09 | $0.11 | -18.2% | $106.9M |
| Feb 26, 2026 | $0.09 | $0.11 | -18.2% | $103.6M |
| Nov 6, 2025 | $0.14 | $0.11 | +27.3% | $104.6M |
| Aug 6, 2025 | $0.07 | $0.10 | -30.0% | $104.6M |
| May 5, 2025 | $0.14 | $0.13 | +7.7% | $106.0M |
| Feb 26, 2025 | $0.15 | $0.13 | +15.4% | $100.4M |
| Nov 6, 2024 | $0.13 | $0.11 | +18.2% | $94.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 27.5× | — | — | — |
| EV / EBITDA | 18.8× | — | — | Top 21% |
| EV / Sales | 3.83× | — | — | Top 46% |
| Free-cash-flow yield | 4.23% | — | — | Top 21% |
| Earnings yield | -4.74% | — | — | Top 43% |
P/E over the past five years
Range 149.1× – 269.2× since Dec 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -30.0%
- Earnings per share growth (TTM)
- -981.5%
- Change in P/E multiple
- -17.3%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 15
- Days above the 200-day average
- 49
- 50-day average slope (20 days)
- +9.3%
- 200-day average slope (20 days)
- -0.5%
- Distance from 50-day average
- +13.2%
- Distance from 200-day average
- +30.3%
- RSI (14)
- 67.1
- Relative volume
- 0.99×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.4%
- Volatility vs own 5-year history
- 23th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.82
- Correlation with S&P 500
- 0.43
- Current drawdown from 1-year high
- -31.2%
- Maximum drawdown, 3 years
- -77.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 4, 2021 | May 15, 2026 | -90.1% | 1135 days | Not yet recovered |
| Dec 23, 2020 | Jul 15, 2021 | -39.1% | 139 days | 74 days (Oct 28, 2021) |
| Dec 11, 2020 | Dec 14, 2020 | -11.8% | 1 days | 2 days (Dec 16, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.46B
- EPS, diluted (TTM)
- -$0.44
- Revenue (TTM)
- $408.4M
- 52-week range
- $4.45 – $13.88
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $286.1M | $335.6M | $354.3M | $385.1M | $418.8M |
| Gross profit | $174.5M | $203.1M | $213.3M | $230.6M | $257.7M |
| Operating income | $13.6M | $32.5M | -$40.8M | -$1.7M | $21.0M |
| Net income | -$13.3M | $14.7M | -$55.4M | -$12.1M | -$1.6M |
| EPS (diluted) | -$0.09 | $0.09 | -$0.35 | -$0.08 | -$0.01 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $94.8M | $100.4M | $106.0M | $104.6M | $104.6M | $103.6M | $106.9M | $93.3M |
| Net income | -$1.4M | $6.6M | $4.7M | -$2.0M | $1.5M | -$5.9M | -$8.8M | -$55.3M |
| EPS (diluted) | -$0.01 | $0.04 | $0.03 | -$0.01 | $0.01 | -$0.04 | -$0.06 | -$0.36 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $60.4M | $92.5M | $82.8M | $80.5M | $96.3M |
| Capital expenditure | -$8.9M | -$12.5M | -$15.3M | -$21.0M | -$26.6M |
| Free cash flow | $51.5M | $80.0M | $67.4M | $59.4M | $69.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $133.4M | $0 | $0 | $0 | -$42.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $184.1M
- Total assets
- $1.40B
- Total liabilities
- $433.3M
- Total debt
- $291.8M
- Net debt
- $107.7M
- Shareholders’ equity
- $966.5M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 28,814,125
- Days to cover
- 15.03
- Change vs previous report
- -0.6%
FINRA short interest, settlement date Sep 15, 2026.